BridgeBio Pharma Research and Development Expenses 2018-2024 | BBIO
BridgeBio Pharma research and development expenses for the twelve months ending June 30, 2024 were $0.511B, a 33.16% increase year-over-year.
- BridgeBio Pharma annual research and development expenses for 2023 were $0.456B, a 14.08% increase from 2022.
- BridgeBio Pharma annual research and development expenses for 2022 were $0.399B, a 11.43% decline from 2021.
- BridgeBio Pharma annual research and development expenses for 2021 were $0.451B, a 33.82% increase from 2020.